NCT00003534 2018-01-31Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate CancerBurzynski Research InstitutePhase 2 Withdrawn
NCT01260103 2017-07-26Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway GliomaBurzynski Research InstitutePhase 3 Withdrawn